『Collaborative Psychiatry QuickTakes』のカバーアート

Collaborative Psychiatry QuickTakes

Collaborative Psychiatry QuickTakes

著者: Collaborative Psychiatry
無料で聴く

このコンテンツについて

Short, high-yield tips on managing mental health disorder in primary care and other non-psychiatric settings. For more information on managing mental health in primary care, see our website at collaborative-psychiatry.org. To access the printable PDF clinical resources and patient handouts associated with each episode, check out the QuickTake pages at collaborative-psychiatry.org/quicktakes.© 2025 Collaborative Psychiatry 教育 科学
エピソード
  • Psychiatric Screeners in Primary Care: Cutting Through the Noise
    2025/12/15

    Get more high-yield learning on psychiatric management in primary care and outpatient practice at collaborative-psychiatry.org.

    In this high-yield episode, we break down five psychiatric screeners every primary care provider should have in their toolbox: the PHQ-9, GAD-7, C-SSRS, Rapid Mood Screener, and Maclean Screening Instrument for BPD. You'll learn when and how to use each screener to streamline your workflow, sharpen your diagnostic thinking, and navigate complex mental health presentations. Whether you're managing depression, anxiety, suicidality, bipolar disorder, or borderline traits, these tools can help you focus your assessment and guide smarter treatment decisions--without adding to your cognitive load or taxing your time.

    For access to the Show Notes as well as the downloadable clinical references and patients handouts associated with this episode, visit the Episode Page. There you will find:

    • Direct links to all screeners discussed in this episode
    • A quick-reference chart reviewing the most helpful psychiatric self-report screeners for general use in primary care
    • A flow chart describing how and when to use psychiatric screeners in your clinical workflow
    • A quick-reference chart describing a case-based approach to use of these screeners
    • A quick-reference tool to assist in differentiating Bipolar Disorder from Borderline Personality Disorder, including questions you can use to guide the process.

    For a deep dive on managing antidepressants and treating depression in primary care, check out our Audio Course on Managing Depression in Primary Care.

    Learning Objectives

    By the end of this episode, you'll be able to:

    1. Identify a go-to psychiatric screener for depression, anxiety, suicidality, bipolar disorder, and borderline personality disorder in primary care.
    2. Determine when to use each screener—before, during, or between visits—to streamline your workflow.
    3. Apply targeted screening to help distinguish between complex conditions such as bipolar disorder and borderline personality disorder.
    続きを読む 一部表示
    15 分
  • Buprenorphine from the Ground Up: Understanding Mechanism, Safety and Clinical Use
    2025/12/01

    Get more high-yield learning on psychiatric management in primary care and outpatient practice at collaborative-psychiatry.org.

    Buprenorphine is one of the most powerful tools we have to fight the opioid epidemic but many primary care providers still feel uncertain about how and when to use it. In this episode, we break down the key pharmacologic concepts behind buprenorphine’s safety, misuse potential, and clinical challenges. By the end, you’ll have a clearer understanding of partial agonism, receptor affinity, and the mechanism behind precipitated withdrawal—so you can prescribe with more confidence.

    For access to the Show Notes as well as the downloadable clinical references and patients handouts associated with this episode, visit the Episode Page. There, QuickTake Members will find:

    • A quick-reference review of how buprenorphine works
    • A suboxone initiation guide
    • A patient handout on precipitated withdrawal

    For a deep dive on managing antidepressants and treating depression in primary care, check out our Audio Course Managing Depression in Primary Care.

    Learning Objectives

    By the end of this episode, you'll be able to:

    1. Differentiate between partial and full agonism at the mu opioid receptor, and explain how partial agonism contributes to buprenorphine’s safety and reduced misuse potential.
    2. Describe the clinical implications of buprenorphine’s high receptor affinity, including its blocking effect on full agonist opioids.
    3. Analyze the receptor-level mechanism of precipitated withdrawal, and identify the conditions under which it may occur.
    続きを読む 一部表示
    15 分
  • Stimulants, Simplified: A Primary Care Framework for Choosing and Using ADHD Meds
    2025/11/17

    Feeling overwhelmed by the endless list of ADHD medications? In this episode, we break down stimulant prescribing into a simple, practical framework designed for busy primary care providers. You’ll learn how to distinguish between amphetamine and methylphenidate classes, when to start with each, and how to think about long-acting vs. short-acting formulations. By the end, you’ll feel more confident starting and adjusting the core stimulant medications, without needing to memorize the innumerable brand names. Whether you're new to ADHD treatment or just looking for a clearer mental model, this episode offers a streamlined approach you can put into practice right away.

    For access to the Show Notes as well as the downloadable clinical references and patients handouts associated with this episode, visit the Episode Page. There, QuickTake Members will find:

    • A stimulant reference chart
    • A stimulant prescribing flowchart
    • Patient handouts on amphetamines and methylphenidates
    • A stimulant medication and skill use tracker for patients

    For a deep dive on managing antidepressants and treating depression in primary care, check out our Audio Course Managing Depression in Primary Care.

    Learning Objectives

    By the end of this episode, you'll be able to:

    1. Identify the two main stimulant classes used to treat ADHD in adults and understand their core similarities and differences.
    2. Apply a practical framework for choosing between amphetamine and methylphenidate classes based on symptom severity and patient characteristics.
    3. Confidently select from a core group of stimulant medications and adjust dosing using long-acting and short-acting formulations for optimal symptom control throughout the day.
    続きを読む 一部表示
    17 分
まだレビューはありません